Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson's disease.
Level 2 - randomized trial
Small randomized controlled pilot trial
PubMed 23636255 · doi:10.1097/WNR.0b013e328361dc13
What was done
Four patients with early-stage Parkinson's disease (PD) were randomized to either intensive exercise (treadmill training 3 times/week for 8 weeks) or a no-exercise control group. Two healthy age-matched individuals also underwent the treadmill training. Striatal dopamine D2 receptor (DA-D2R) binding potential was measured pre- and post-intervention using PET imaging with [18F]fallypride. Clinical outcomes assessed included turning performance (postural control) and Unified Parkinson's Disease Rating Scale (UPDRS) scores.
What was found
The abstract reports that patients with PD who exercised showed an increase in [18F]fallypride binding potential and improved postural control (turning performance). No changes in DA-D2R binding potential were observed in non-exercising PD patients. Specific numerical values, effect sizes, and UPDRS score changes were not reported in the abstract.
Why it matters
This pilot study provides initial translational evidence in humans that intensive aerobic exercise may modulate central dopaminergic neuroplasticity and improve motor function in early-stage Parkinson's disease.
Limits
The sample size is extremely small (4 PD patients and 2 healthy controls), significantly limiting statistical power and generalizability. Exact quantitative results, confidence intervals, and p-values are omitted from the abstract. Long-term retention of receptor changes and motor improvements was not evaluated.
Cited by
- partial Eight weeks of intensive treadmill training three times per week increases dopamine receptor expression in the basal ganglia by 80 to 90 percent in Parkinson's disease patients.
- supports In a pilot trial of newly diagnosed, medication-free Parkinson's patients, moderate-to-high intensity treadmill exercise increased dopamine receptor expression in the brain.